Aclaris Therapeutics
(NASDAQ) ACRS
Aclaris Therapeutics Financials at a Glance
Market Cap
$608.94M
Revenue (TTM)
$8.37M
Net Income (TTM)
-$69.66M
EPS (TTM)
-$0.56
P/E Ratio
-7.78
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$4.35
Volume
1,086,083.277
Open
$4.37
Price
$4.35
Volume
1,086,083.277
Open
$4.37
Previous Close
$4.34
Daily Range
$4.25 - $4.43
52-Week Range
$1.34 - $5.15
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$4.35
Volume
1,086,083.277
Open
$4.37
Previous Close
$4.34
Daily Range
$4.25 - $4.43
52-Week Range
$1.34 - $5.15
Estimated Earnings Date
Aug 6, 2026
ACRS News
The Best IPOs of 2015
ACRS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aclaris Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
73
CEO
Neal S. Walker, PhD, MBA
Website
www.aclaristx.comHeadquarters
Wayne, PA 19087, US
ACRS Financials
Key Financial Metrics (TTM)
Gross Margin
76%
Operating Margin
-10%
Net Income Margin
-8%
Return on Equity
-48%
Return on Capital
-47%
Return on Assets
-35%
Earnings Yield
-12.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$608.94M
Shares Outstanding
139.66M
Volume
1.09M
Avg. Volume
1.40M
Financials (TTM)
Gross Profit
$5.74M
Operating Income
-$76.38M
EBITDA
-$64.47M
Operating Cash Flow
-$47.11M
Capital Expenditure
-$111.00K
Free Cash Flow
-$47.11M
Cash & ST Invst.
$90.75M
Total Debt
$2.12M
Aclaris Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.00M
+37.2%
Gross Profit
$1.60M
+68.7%
Gross Margin
80.21%
N/A
Market Cap
$608.94M
N/A
Market Cap/Employee
$9.98M
N/A
Employees
61
N/A
Net Income
-$19.82M
-31.4%
EBITDA
-$19.72M
-11.7%
Quarterly Fundamentals
Total Cash
$105.42M
+0.1%
Total Debt
$1.99M
-20.1%
Accounts Receivable
$4.81M
+1825.6%
Inventory
$0.00
N/A
Long Term Debt
$1.42M
-28.7%
Short Term Debt
$569.00K
+14.3%
Return on Assets
-35.06%
N/A
Return on Invested Capital
-46.97%
N/A
Free Cash Flow
-$18.15M
-38.5%
Operating Cash Flow
-$18.15M
-39.0%